SXI Life Sciences
7.099,32
PKT
+70,81
PKT
+1,01
%
Werbung
Analysen zu SXI Life Sciences-Werten
Datum | Rating | Analyst | |
---|---|---|---|
24.01.05 | Novartis Neutral | Sarasin Research | |
25.01.05 | Novartis Neutral | Sarasin Research | |
24.01.05 | Straumann Outperform | Credit Suisse First Boston | |
21.01.05 | Roche Buy | Sarasin Research | |
24.01.05 | Lonza Reduce | Sarasin Research | |
21.01.05 | Novartis Kaufen | Helaba Trust | |
24.01.05 | Novartis Neutral | HypoVereinsbank | |
24.01.05 | Novartis Kaufen | Hamburger Sparkasse | |
20.01.05 | Novartis Hold | SEB | |
20.01.05 | Novartis Akkumulieren | Independent Research | |
20.01.05 | Novartis Neutral | Sarasin Research | |
21.01.05 | Novartis Buy | Helvea | |
19.01.05 | Novartis Equal-weight | Morgan Stanley | |
19.01.05 | BB Biotech Kaufen | Hamburger Sparkasse | |
19.01.05 | Tecan (N) Reduce | Helvea | |
19.01.05 | Straumann Accumulate | Helvea | |
21.01.05 | Novartis Kaufen | Helaba Trust | |
18.01.05 | Novartis Buy | AG Edwards | |
18.01.05 | Novartis Buy | Merrill Lynch | |
18.01.05 | Novartis Outperform | Bear Stearns | |
18.01.05 | Lonza Buy | Helvea | |
18.01.05 | Roche Buy | Merrill Lynch | |
18.01.05 | Siegfried Neutral | Helvea | |
18.01.05 | Novartis Buy | Sarasin Research | |
18.01.05 | Novartis Buy | Merrill Lynch | |
18.01.05 | Novartis Akkumulieren | Independent Research | |
17.01.05 | Lonza Reduce | Sarasin Research | |
17.01.05 | Novartis Sector Outperform | Vontobel | |
14.01.05 | Novartis Kaufen | Helaba Trust | |
14.01.05 | Novartis Overweight | Lehman Brothers | |
18.01.05 | Novartis Empfehlungsliste | Erste Bank | |
18.01.05 | Straumann Outperform | Credit Suisse First Boston | |
17.01.05 | Tecan (N) Neutral | Credit Suisse First Boston | |
17.01.05 | Basilea Pharmaceutica Outperform | Credit Suisse First Boston | |
17.01.05 | Sonova Outperform | Credit Suisse First Boston | |
13.01.05 | Novartis Buy | AG Edwards | |
12.01.05 | Novartis Hold | Smith Barney Citigroup | |
13.01.05 | Novartis Kaufen | Hamburger Sparkasse | |
11.01.05 | Novartis Sell | Banc of America Sec. | |
10.01.05 | Lonza Underperform | Goldman Sachs |